November 13-14, 2018

Boston, MA, USA

Partnership Opportunities

Are you front of mind when pharma and biotech look to develop commercially viable complement therapeutics?

Key complement-based drug developers have informed us that one of the most pressing problems in this rapidly growing field is that service providers lack knowledge and experience of the industry, forcing developers to use time and resources on work that they would rather outsource.

The Complement-based Drug Development Summit will allow sponsors to gain a deep understanding of the most pressing concerns that the industry leading developers have with CROs, CMOs and Assay Service Providers/Vendors, and strategies for how these could be overcome. Partnering with us will enable you to meet with high-level representatives from a range of companies, hear exactly what criteria they use to select vendors, and act on these insights to offer highly tailored products and services for complement therapeutics.

This is an unparalleled opportunity to demonstrate that you have the desire and capability to meet the increasing demands of this emerging field, and cement your position as the industry leader.

    • Present and position your capabilities to key decision makers from pharmaceutical developers who are actively seeking new solutions to optimize drug discovery inefficiencies
    • Meet and interact with stakeholders throughout the field trying to integrate and implement these technologies
    • Deliver a thought-leading presentation to differentiate yourself from your peers by demonstrating your specific expertise and technology
    • Meet all the business contacts you need across 3 days – take advantage of 1-2-1 networking time with your target audience

If you have a product or service that will benefit this audience, please contact Jonathan Kilby-Phillips and Philip Johnson


Phone: +1 212 537 5898




A very targeted meeting filled with KOLs and industry leaders in this exciting field.  The meeting was organized and run better than any other trade show I have attended.”
Past summit attendee David Choiniere, IntelliCyt